Flu Vaccine News
Most Popular Flu Vaccine Story
Tamiflu weakness is Glaxo's strength
Where Roche's Tamiflu loses, GlaxoSmithKline wins. The Centers for Disease Control and Prevention says that one strain of this year's seasonal flu, the H1N1 virus, is increasingly resistant to Read more...
Latest Headlines
- August 31, 2010
- June 29, 2010
- March 16, 2010
- January 11, 2010
- January 8, 2010
- January 5, 2010
- November 6, 2009
- October 26, 2009
- October 2, 2009
- August 18, 2009
- May 14, 2009
- April 29, 2009
- April 27, 2009
- December 22, 2008
- August 7, 2008
- June 24, 2008
- May 20, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
